CAPRICOR THERAPEUTICS, INC. Grants Receivable, Current
CAPRICOR THERAPEUTICS, INC. (CAPR) had Grants Receivable, Current of $0 as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes
us-gaap:GrantsReceivableCurrent · last filed 2026-05-13
- 2026-03-31: Grants Receivable, Current $0.00.
- 2025-12-31: Grants Receivable, Current $59.17K.
- 2025-09-30: Grants Receivable, Current $59.17K.
- 2025-06-30: Grants Receivable, Current $59.51K.
| Period end | Grants Receivable, Current |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 |
| 2025-12-31 | $59.17K 10-Q · filed 2026-05-13 |
| 2025-09-30 | $59.17K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $59.51K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $59.83K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $10.37M 10-K · filed 2026-03-17 |
| 2024-09-30 | $409.68K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $369.98K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $369.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $10.37M 10-K · filed 2025-03-26 |
| 2023-09-30 | $547.58K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $547.58K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $547.58K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $547.58K 10-K · filed 2024-03-11 |
| 2022-09-30 | $547.58K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $547.58K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $357.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $391.75K 10-K · filed 2023-03-17 |
| 2021-09-30 | $180.18K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |
| 2020-09-30 | $16.86K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $49.86K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $118.63K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $87.97K 10-K · filed 2021-03-15 |
| 2019-09-30 | $101.25K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $144.09K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $122.62K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $204.87K 10-K · filed 2020-03-27 |
| 2018-09-30 | $172.59K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $287.30K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $306.75K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $344.57K 10-K · filed 2019-03-29 |
| 2017-09-30 | $537.03K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $312.87K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $197.21K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $223.34K 10-K · filed 2018-03-22 |
| 2016-09-30 | $1.16M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $218.36K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $303.63K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $211.94K 10-K · filed 2017-03-16 |
| 2015-09-30 | $403.43K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $380.01K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $746.24K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $360.23K 10-K · filed 2016-03-30 |
| 2014-09-30 | $259.80K 10-Q · filed 2014-11-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2012-12-31 | $767.16K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |